FilingReader Intelligence
Lukang Pharmaceutical gets exchange approval for private placement
August 21, 2025 at 05:00 AM UTC•By FilingReader AI
Shandong Lukang Pharmaceutical Company Limited announced on August 20 that the Shanghai Stock Exchange approved its private placement application.
The exchange confirmed the application met requirements and will submit it to the China Securities Regulatory Commission for final registration approval.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Shandong Lukang Pharmaceutical publishes news
Free account required • Unsubscribe anytime